A study of more than 110,000 women found those who took popular GLP-1 drugs prescribed for obesity or diabetes had a lower ...

Inclusion of weight loss drugs on insurer formularies is a meaningful step towards expanding access. But having a product ...

An expert explains how the new program, which launches July 1, will work and who is eligible ...

CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...

Weight loss drugs may significantly reduce need for knee replacement surgery, new study suggests - New research has ...

Eli Lilly this month unveiled startling new data that showed an experimental weight-loss drug caused people with obesity to ...

Eli Lilly's new experimental weight loss drug retatrutide yielded up to 28% weight loss, which is greater than that of ...

Weight loss jabs are transforming obesity treatment, but without access to affordable healthy food and ongoing support they ...

GLP-1 medications may offer significant benefits, but for some people with a history of anorexia, weight loss itself can ...

CVS Health will restore Eli Lilly’s weight-loss injection Zepbound to its list of covered drugs and also add the drugmaker’s ...

More obesity patients are turning to drugs like Ozempic and Zepbound instead of having bariatric surgery. But most don't receive either treatment.

Weight loss medications, including popular drugs like Ozempic and Wegovy, could significantly reduce the need for knee ...